Exchange: NASDAQ·Updated 04:10 PM EDT
NGEN logo

NGEN NervGen Pharma Corp

$2.21
$0.07
(3.07%)
Today
Closed $2.21
$0.00
(0.00%)
After Hours
Reported EarningsAug 13
Mkt Cap$245.15M
Vol795,160.00

About NGEN

NervGen Pharma Corp. operates as a clinical stage biotech company. It engages in the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
86

Extremely Bullish Sentiment

How do you feel about NGEN?

Advertisement|Remove ads.